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Introduction
Hyperthermia (HT), i.e., increasing tumor temperature to 41-45 C for one hour, is a proven radiotherapy (RT) and chemotherapy sensitizer [1] [2] [3] . HT delivery is monitored using temperature sensors, but the required minimum number of sensors has not been identified. Unlike chemotherapy or RT, delivery of a prescribed HT dose is challenging due to limited number of sensors, patient-specific anatomy, and patient-specific response to heat treatment. The HT dose that can be given often depends on the maximum temperature patients can tolerate, which is unknown prior to treatment and may vary in subsequent treatments. In addition, temperature uniformity is not guaranteed due to heterogeneous power deposition and heterogeneous perfusion, which is tissue, time and temperature dependent [4] . For various tumor types, e.g., sarcoma, melanoma, head and neck cancer, and recurrent breast cancer, tumor response and local control were shown to be related to minimum temperature (T min ) and the 90th percentile of temperatures (T90) achieved in the treatment area during HT [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] . In addition, there is a clear relationship between maximum temperature (T max ) and HT associated toxicity [12, 15, [17] [18] [19] [20] [21] . Recent consensus advocate that T max should not exceed 43-45 C [4] . This statement is supported by an observational study of 262 female patients treated for recurrent breast cancer with reirradiation (reRT) and HT: no HT associated toxicity occurred when T max remained below 43.0 C, while the probability of a seconddegree burn was 5% when T max was 43.7 C [17] . These conclusions highlight the need to find the delicate balance between optimizing HT for best tumor response while minimizing toxicity by avoiding excessively low and excessively high temperatures.
Adequate thermometry is critical for successful HT treatments. Techniques to measure temperature during HT include fiber-optic probes, thermistors and thermocouples [4, 22] . A disadvantage associated with these methods is that temperature is often recorded using a small number of temperature sensors. The European Society for Hyperthermic Oncology (ESHO) technical committee recommended a minimum of five different locations to measure skin temperature every minute during superficial HT. But measuring at just five skin locations may result in under sampling when significant temperature gradients are present, particularly within large treatment areas. Spatial temperature gradients of 1.6 C/cm have been reported for head and neck [23] . Thermal mapping is an alternative technique that involves moving singlesensor probes cyclically over a fixed trajectory to cover multiple measurement locations with a single sensor. Despite the lower temporal resolution, mapping significantly improves the spatial resolution [24] .
For recurrent breast cancer treated with reRT þ HT, the reported number of temperature sensors varies between 1 and 82, with a median of 8 per study [9, 12, 15, 17, 19, 20, [25] [26] [27] . Major suppliers of superficial HT equipment offer 4-32 sensors (ALBA ON 4000, Medlogix, Italy) or 4-8 sensors (BSD-500, Pyrexar, Salt Lake City, UT, USA). At the Academic Medical Center (AMC, Amsterdam, The Netherlands) tumor temperatures are monitored with more than 80 sensors ( Figure 1 ) using a 196-channel thermometry system (UMCU, Utrecht, The Netherlands).
HT aims to maximize tumor response while minimizing the risk of HT associated toxicity. To help achieve this goal, we performed a simulation study using subsets of skin temperatures measured during superficial HT treatments of patients with recurrent breast cancer treated with reRT þ HT at the AMC. Two reduced temperature monitoring schemes were considered: (1) subsets of randomly selected stationary temperature sensors; and (2) a thermal mapping subset. These subsets were compared in terms of adequate thermometry coverage, thus establishing the minimum required number of sensors during superficial HT. In addition, we investigated the proportion of HT sessions in which a maximum skin temperature exceeding 43.0 C goes undetected while using smaller subsets of sensors.
Methods
Between February 2015 and June 2017, 137 patients were treated with RT and superficial HT using one or two applicators of the ALBA 4000 Double-ON system (Medlogix, Rome, Italy). Of these, 80 patients presented recurrent breast cancer and were reirradiated with 23 Â 2 Gy and five weekly HT sessions. The other 57 patients were excluded from this study for various criteria identified in Figure 2 . Median age at start of treatment was 66 years (range 40-88). Patients had been treated previously with surgery (n ¼ 79), chemotherapy (n ¼ 47), hormonal therapy (n ¼ 44) and radiotherapy (n ¼ 80) with 60.2 ± 8.8 Gy (mean ± SD; range 40-76). Nine patients had macroscopic tumor, whereas in the other 71 patients, the recurrent tumor had been surgically removed before reRT þ HT.
HT objectives were to elevate temperatures in the target region to a minimum of 41 C for one hour while maintaining maximum skin temperatures below 43.5 C to minimize occurrence of second-degree burns [17] . Skin temperatures were evaluated in terms of overall minimum (T min ) and maximum (T max ) temperature, as well as T90 and T10, which are the 90th and 10th percentile of the temperature measurements during steady state, respectively. HT started within 30-60 min after RT. The HT device consisted of single conformal contact flexible microstrip applicators (CFMA; Istok, Fryazino, Russia) operating at 434 MHz: models 3 H (n ¼ 36), 4 H (n ¼ 1) and 5 H (n ¼ 43) with effective field sizes (EFS) of 396, 216 and 351 cm 2 , respectively [28] . The EFS is defined as the area enclosed within the 50% contour of normalized specific absorption rate (SAR), where the normalization was performed at 1 cm depth in a flat homogeneous phantom [29] . A flat water bag containing temperature-controlled circulating deionized water was placed between antenna and skin to control skin temperature and couple microwave energy to the human body. The water temperature was adjusted within 38-42 C to maintain a minimum temperature of 41 C on the target skin surface. Temperature monitoring was performed with 7-point copper-constantan thermocouple probes (±0.05 C accuracy; ELLA-CS, Hradec Kr alov e, Czech Republic) placed both interstitially and superficially on the skin (Figure 1(A) ). The probes were placed perpendicular to the dominant direction of the electromagnetic field to avoid self-heating of the thermocouple probes. Power of the microwave device was on for 25 s and then off for 1 s to enable electronically undisturbed temperature measurements once every 26 s with a 196-channel thermometry system (UMCU, Utrecht, The Netherlands). Note that superficial temperature measurements are influenced by water bolus temperature, type of thermometry and the presence of plastic coating and surrounding catheters around the sensor [30, 31] and may thus indicate a temperature lower than the actual temperature a few millimeters deep in the skin [17, 32] . The superficial temperatures were measured with a median of thirteen 7-point probes (range 8-21) and 89 sensors (range 60-147), where broken sensors were excluded from the analysis. No interstitial temperature data are reported in this study.
Subset analysis
The multi-step procedure to randomly select subsets of stationary sensors is illustrated in Figure 3 . First, a patient with one of its corresponding HT sessions was drawn at random. Next, several random sensors of each thermocouple probe positioned on the skin were selected. This resulted in six random subsets (with one to six sensors per 7-point probe) and one non-random selection with all seven sensors of the 7point probe. In subsets with two or three sensors per probe, selected sensors were not allowed to be adjacent. The parameters T min , T90, T10 and T max of the session were calculated for each sensor selection. To increase the statistical significance, these steps were repeated 5000 times, i.e., each HT session was sampled approximately 12 times.
Thermal mapping was simulated as cyclically pulling a sensor in a sawtooth fashion along the 6 cm trajectory of the 7-point probe with a temperature measurement performed every 26 s and every 1 cm, which resulted in a seven-fold reduction in temporal resolution. The transformation of the full set of stationary temperature measurements into a temporal selection of points representing continuous thermal mapping is a non-randomized selection process, which we call 'thermal profiles' throughout the manuscript to differentiate from traditional thermal mapping. Table 1 shows an example of the temporal distribution of the first 20 temperature measurements. This was performed for all five HT sessions of all 80 included patients, using all available superficial temperature measurements ( Figure 3 ). All simulations were implemented in Matlab R2016a (MathWorks, Natick, MA, USA) using the default random seed.
To compare the different subsets to the full set of sensors, we calculated their temperature difference (DT) for each simulation. This procedure was repeated for the thermal profile subset. Furthermore, we compared the results for scar and other superficial tissue, as well as for different HT applicators. Finally, we investigated the proportion of treatments where a Between February 2015 and June 2017, 137 patients were planned to be treated with reirradiation (23 × 2 Gy) and superficial hyperthermia (HT).
Reasons for exclusion:
-11 patients had no recurrent breast cancer -19 patients were not treated with 23 × 2 Gy -1 patient received concurrent chemotherapy 106 patients with recurrent breast cancer were treated with 23 × 2 Gy and HT
-6 patients received <5 HT treatments -1 patient was treated with >1 applicator -18 patients had <60 temperature sensors 81 patients with recurrent breast cancer were treated with 23 × 2 Gy and weekly HT with one applicator and >60 temperature sensors on the skin
-1 patient was lost to follow-up 80 patients were included, resulting in a total of 400 HT sessions T max ! 43.0 C was identified using the full set of sensors.
Using a random selection of these sensors, we simulated the proportion of subsets that still identified a T max ! 43.0 C. Thermometry coverage is well characterized by T90 and T max , which correlate with tumor response and toxicity, respectively. We define thermometry coverage as adequate if DT 95% CI 0.5 C for both T90 and T max . This criterion is based on accepting maximum detected temperatures of 43.0 C, with a deviation 0.5 C. True maximum temperatures may rise up to 43.5 C, which presents a very small probability (3%) of a second-degree burn [17] . Finally, we investigated spatial temperature gradients on the skin.
Statistical analysis
No correction for stratified sampling was applied because we analyzed the highest and lowest temperature values and not the median or average. Median treatment parameter statistics, 25th and 75th interquartile and 95% CI are reported.
recurrent breast cancer patients treated at the AMC between February 2015 and June 2017 with reirradiation (23×2 Gy) and five weekly sessions of 434 MHz hyperthermia (HT)

Thermal mapping simulation Stationary sensors simulation
Step 1. Thermal mapping was simulated for all five HT sessions of the 80 included patients, according to the sawtooth profile introduced in Table 1 . This was performed for all 7-point thermocouple probes positioned on scar or skin tissue.
Step 2. One patient was drawn at random.
Step 3. One session out of five was drawn at random.
Step 4. For each 7-point thermocouple probe positioned on scar or skin tissue during the HT session, six times a random selection of the sensors was performed with an increasing number of sensors per probe and once a nonrandom selection: a. Random selection of one sensor per probe; b. Random selection of two sensors per probe (not allowed to be adjacent); c. Random selection of three sensors per probe (not allowed to be adjacent); d. Random selection of four sensors per probe; e. Random selection of five sensors per probe; f. Random selection of six sensors per probe; g. Selection of all seven sensors per probe.
Step 5. Temperature parameters per HT session were calculated, including minimum and maximum temperature, and T90 and T10, which are the 90th and 10th percentile of temperature measurements during steady state, respectively.
Step 6.
a. Steps 1 and 5 were repeated 400 times to generate the results of the thermal mapping simulation. b. Steps 2-5 were repeated 5000 times to generate the results of the simulation study consisting of stationary sensors. 
Results
The DT between the complete set (range 60-147 sensors) and randomly selected subsets of superficial sensors (range 8-126 sensors) during a HT session are displayed in Figure 4 .
In general, T min and T max show more variation than T90 and T10. Remarkably, T90 and T10 have a median temperature difference <0.01 C across the different subsets of sensors and small 95% CI, which decrease below 0.5 C when using >50 and >30 sensors for T90 and T10, respectively. Small subsets of sensors result in overestimation of T min and underestimation of T max (Figure 4) , and by increasing the number of sensors the over and underestimation of T min and T max decreased, respectively. The median DT associated with T max was <À0.01 C when >20 sensors were randomly selected, its 95% CI decreased below À0.5 C when >50 sensors were selected. Thermal profiles (17 profiles, median 13 trajectories, range 8-21) showed a median DT <0.01 C for T90 and T max for all 400 HT sessions. The corresponding 95% CI were small: À0.2 C and 0.4 C for T90 and T max , respectively (Figure 4) . A T max !43.0 C was identified in 50.0% of the HT sessions (200 out of 400) and in 50.5% of the simulations (2524 out of 5000). Figure 5 shows that at least 50% of the sessions with temperatures !43.0 C were not detected when 20 sensors were used. Doubling the number of sensors to 40 increased the detection rate to 80%. Thermal profiles identified treatments with temperatures !43.0 C in 85% of the simulations, which is comparable using 50 stationary sensors.
Finally, when the temperature results of scar were analyzed separately from other superficial tissue, the temperature differences of scar presented lower absolute medians and smaller DT 95% CI for all four parameters (T min , T90, T10 and T max ). For example, for subsets of <10 stationary sensors the median DT T max was À0.1 C (scar) vs. À0.4 C (other superficial tissue). Furthermore, for patients treated with the 3 H applicator (EFS ¼ 396 cm 2 , n ¼ 36) the temperature difference showed wider DT 95% CI for all four parameters compared to the 5 H applicator (EFS ¼ 351 cm 2 , n ¼ 43). For example, for subsets of <10 stationary sensors, the DT 95% CI of Tmax was À2.7 C (3H) vs. À1.7 C (5H). In the 400 HT sessions, the median maximum spatial temperature gradient measured on the skin was 1.1 C/cm (range 0.3-1.9 C/cm).
Discussion
A simulation study was performed using clinical superficial temperature measurements of HT treatments of patients with recurrent breast cancer treated with reRT þ HT at the AMC. Using a large set of clinical data with detailed temperature recordings (!60 sensors), subsets with an increasing number of skin temperature sensors were randomly selected. The corresponding T min , T90, T10 and T max parameters were calculated. A similar analysis was performed for another subset of the clinical data, where we simulated the use of thermal mapping.
We found that T90, T10 and T max are generally robust parameters that can be detected within 0.5 C as measured by the DT 95% CI using: >50 stationary sensors (T90 and T max ), >30 stationary sensors (T10), or using thermal profiles (T90, T10 and T max ). Furthermore, median DT of T90 and T10 was <0.01 C even when using <10 sensors. These findings indicate that T90 and T10 parameters can be used to compare HT treatments between different HT centers or between different sources in literature. However, for comparison purposes, we recommend a DT 95% CI 1.0 C, which implies the use of at least 20 stationary sensors or thermal profiles. Regardless of the comparison, the quality of thermometry remains highly dependent on a rigorous spatial sensor distribution that should capture all heterogeneities in superficial tissue, including scars. Note that T90 and T10 derived from skin temperature sensors do not represent the dose in the entire tumor. The quality of hyperthermia treatment is more dominantly determined by interstitial temperature (dose) values, the ESHO technical committee therefore strongly advises to measure both superficial and interstitial temperatures during hyperthermia treatment [4] .
The minimum and maximum temperatures deviate significantly for a low number of sensors (Figure 4 ). For <10 sensors T max can be underestimated with a DT 95% CI of 2.1 C. This can have serious implications for the estimated toxicity based on temperature values during HT, since the probability of a second-degree burn will significantly increase when a T max of 43 C is underestimated by 2.1 C [17] . To reduce the risk of missing a temperature peak, one would need >100 temperature sensors on the skin during HT treatment ( Figure 5 ). However, even our complete set of thermometry does not fully cover the entire treatment area. Sensors within a probe are located at 1 cm distance, thus a temperature peak of 44.0 C is unlikely but theoretically possible between two neighboring sensors both measuring 43.0 C, based on the highest expected gradients of 1.9 C/cm. Such a temperature peak would still be below the typical pain threshold of 44.5 C [21, 33] and would give 10% probability on a second-degree burn [17] . However, the distance between different probes positioned on the skin was more than 1 cm (Figure 1(A) ). It would thus be necessary to place a temperature sensor on every 1 cm 2 if one would want to limit the maximum possible temperature peak to 44.0 C throughout the target area. In alternative, the maximum temperature limits during HT treatment could be reduced depending on the number of sensors that was used (Figure 4 ), For example, when <10 sensors were placed on the skin, a reduction of 0.9 C in the maximum temperature limit, from 43.7 C to 42.8 C, would leave 25% of the HT sessions at risk for undetected temperatures above 43.7 C, i.e., !5% probability on a second-degree burn [17] .
Thermal mapping is a strategy to increase thermometry coverage using a relatively low number of sensors. There are many thermal mapping protocols, e.g., mapping a trajectory of 14 cm in 1 cm increments, performed at 5 min intervals [34] or using essentially stationary sensors with whom a manual map is performed 2-3 times during treatment [24] . Without loss of generality, we choose to implement a simple, logical and generic thermal mapping procedure with our dataset. The implemented thermal mapping procedure entails more thermal profiles per treatment (17 profiles) than standard practice reported in literature for thermal mapping (2-10 maps), furthermore shorter trajectories (6 cm) were taken into account than standard practice reported in literature (14 cm) . In our study, thermal profiles performed much better than the same number of stationary sensors (median 13, range 8-21); and its performance was comparable to 31-40 stationary sensors in terms of T min , T90, T10 and T max ( Figure 4 ). It increased the detection rate of temperatures above 43 C from 40% to 85% ( Figure 5 ). Therefore, thermal mapping is strongly recommended when there are only a few sensors available, as with current commercially available superficial HT equipment, under the condition that thermal mapping is performed at least every 5-10 minutes to gain sufficient maps during the treatment. The effectiveness of thermal mapping could be further extended by optimizing the mapping trajectories, the acquisition time, and steps per map, so that the density of sampled temperature points under the applicator is increased.
Part of the temperature sensors were placed on the surgical scar (28.8%), which is a tissue that tends to overheat due to poor perfusion. The scar showed smaller DT 95% CI than other superficial tissue for all four parameters. We believe this is because sensors on other superficial tissue are distributed over a much wider treatment area with well vascularized tissue, while the scar is mostly concentrated in the middle of the treatment area and poorly vascularized, and thus shows less variation.
Our study was performed mainly with CFMA applicators with relatively large EFS (351-396 cm 2 ). For applicators with smaller EFS, it is plausible to assume that less temperature sensors are required, though temperature gradients may also be larger within the EFS region of smaller applicators, thus requiring a higher spatial resolution. When comparing the 5 H (351 cm 2 ) and 3 H applicator (396 cm 2 ), we found that patients treated with the 3 H applicator had a wider DT 95% CI. We hypothesize that this is due to wider spacing of probes over the larger applicator aperture. Thus, the required minimum number of sensors to adequately monitor temperature parameters depends on applicator size and type. Furthermore, there will also be a tumor-specific, e.g., microscopic vs. macroscopic disease, and patient-specific component, e.g., presence of scars. It should be investigated whether the results of this study are valid for a wider range of applicators, devices and disease types. Nevertheless, this study indicates that there is a need for much higher spatial resolution of temperature sensors than is now general standard practice.
Conclusions
The quality assessment of superficial HT treatment delivery is dependent on temperature feedback from superficial and interstitial temperature readings. To this date, the minimum spatial coverage requirements have not been fully addressed. Based on our study, we conclude that to adequately monitor superficial temperature during superficial HT, >50 stationary sensors per 400 cm 2 applicator are required. Although we advise >100 sensors on the skin to reduce the risk of missing a temperature peak. As an alternative to >50 sensors, the use of continuous thermal mapping with approximately 13 sensors would provide similar effective results in terms of temperature coverage. When only a lower number of sensors is available, the maximum temperature limit during HT should be decreased as a function of the number of sensors used, to minimize toxicity from unrecorded temperature peaks. Our findings indicate that the T90 and T10 parameters can be used to compare HT treatments between different HT centers or different sources in literature with varying number of sensors, provided a minimum of 20 stationary sensors is used.
